Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Conor faces litigation from Boston and Angiotech

This article was originally published in Clinica

Executive Summary

Boston Scientific and Angiotech Pharmaceuticals, the Canadian company from which Boston exclusively licenses its paclitaxel stent-coating technology, have filed a joint lawsuit against Conor Medsystems in the Netherlands. Vancouver-based Angiotech launched the legal action against Menlo Park, California-based Conor after obtaining a favourable decision on its European patent No 0706,376 on January 24.

Topics

UsernamePublicRestriction

Register

MT054222

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel